S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Sell every Stock except ONE (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Bonner’s “4th and Final Prediction”—First 3 came true, will this too? (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War

Bed Bath & Beyond Inc. (NASDAQ:BBBY) CFO Gustavo Arnal Sells 42,513 Shares

Bed Bath & Beyond Inc. (NASDAQ:BBBY - Get Rating) CFO Gustavo Arnal sold 42,513 shares of Bed Bath & Beyond stock in a transaction on Tuesday, August 16th. The stock was sold at an average price of $24.22, for a total transaction of $1,029,664.86. Following the completion of the transaction, the chief financial officer now directly owns 267,896 shares in the company, valued at $6,488,441.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Bed Bath & Beyond Stock Down 19.6 %

Shares of BBBY stock traded down $4.53 during mid-day trading on Thursday, reaching $18.55. 141,110,500 shares of the company's stock traded hands, compared to its average volume of 16,662,459. Bed Bath & Beyond Inc. has a 12 month low of $4.38 and a 12 month high of $30.14. The company has a market cap of $1.48 billion, a P/E ratio of -1.81 and a beta of 1.89. The company has a quick ratio of 0.15, a current ratio of 1.02 and a debt-to-equity ratio of 6.77. The company's 50-day moving average price is $7.12 and its 200-day moving average price is $12.87.


Bed Bath & Beyond (NASDAQ:BBBY - Get Rating) last announced its earnings results on Wednesday, June 29th. The retailer reported ($2.83) EPS for the quarter, missing analysts' consensus estimates of ($1.33) by ($1.50). The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.51 billion. Bed Bath & Beyond had a negative net margin of 11.74% and a negative return on equity of 90.91%. The business's quarterly revenue was down 25.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.05 EPS. On average, equities analysts expect that Bed Bath & Beyond Inc. will post -5.93 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bed Bath & Beyond

Several large investors have recently modified their holdings of BBBY. State of New Jersey Common Pension Fund D raised its position in shares of Bed Bath & Beyond by 18.8% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 120,801 shares of the retailer's stock worth $1,761,000 after purchasing an additional 19,108 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its position in shares of Bed Bath & Beyond by 126.8% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 29,036 shares of the retailer's stock worth $423,000 after purchasing an additional 16,234 shares during the last quarter. Thompson Investment Management Inc. raised its position in shares of Bed Bath & Beyond by 8.1% in the 4th quarter. Thompson Investment Management Inc. now owns 120,760 shares of the retailer's stock worth $1,761,000 after purchasing an additional 9,066 shares during the last quarter. Advisors Preferred LLC purchased a new position in Bed Bath & Beyond in the 4th quarter worth about $2,349,000. Finally, American Century Companies Inc. raised its position in Bed Bath & Beyond by 31.8% in the 4th quarter. American Century Companies Inc. now owns 327,958 shares of the retailer's stock worth $4,782,000 after buying an additional 79,180 shares during the last quarter.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Robert W. Baird downgraded shares of Bed Bath & Beyond from a "neutral" rating to an "underperform" rating and set a $4.00 target price on the stock. in a research note on Tuesday, August 9th. UBS Group cut their price target on shares of Bed Bath & Beyond from $12.00 to $5.00 and set a "sell" rating on the stock in a report on Wednesday, June 22nd. Telsey Advisory Group cut their price target on shares of Bed Bath & Beyond from $6.00 to $3.00 and set an "underperform" rating on the stock in a report on Thursday, June 30th. Odeon Capital Group cut shares of Bed Bath & Beyond from a "hold" rating to a "sell" rating and set a $7.50 price target on the stock. in a report on Tuesday. Finally, Wells Fargo & Company cut their price target on shares of Bed Bath & Beyond from $10.00 to $5.00 and set an "underweight" rating on the stock in a report on Wednesday, June 8th. Thirteen investment analysts have rated the stock with a sell rating and one has given a hold rating to the company's stock. Based on data from MarketBeat, Bed Bath & Beyond has a consensus rating of "Reduce" and a consensus price target of $6.50.

About Bed Bath & Beyond

(Get Rating)

Bed Bath & Beyond Inc, together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products.

Read More

Insider Buying and Selling by Quarter for Bed Bath & Beyond (NASDAQ:BBBY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Bed Bath & Beyond right now?

Before you consider Bed Bath & Beyond, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bed Bath & Beyond wasn't on the list.

While Bed Bath & Beyond currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.